Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
6.46M
-
Shares change
-
+112K
-
Total reported value, excl. options
-
$8.99M
-
Value change
-
+$71.4K
-
Put/Call ratio
-
0.1
-
Number of buys
-
9
-
Number of sells
-
-13
-
Price
-
$1.39
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2023
43 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2023.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.46M shares
of 108M outstanding shares and own 6.01% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.93M shares), BlackRock Inc. (568K shares), VANGUARD GROUP INC (520K shares), GEODE CAPITAL MANAGEMENT, LLC (465K shares), MORGAN STANLEY (218K shares), Cowen Prime Advisors LLC (179K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (176K shares), STATE STREET CORP (124K shares), NORTHERN TRUST CORP (70.1K shares), and Spectrum Asset Management, Inc. (NB/CA) (55.6K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.